Navigation Links
NIH turns to crowdsourcing to repurpose drugs
Date:7/16/2014

New Rochelle, NY, July 16, 2014Experimental drugs proven safe but perhaps not sufficiently effective in initial testing or against a first disease target may sit gathering dust on the shelves of pharmaceutical companies. An NIH-sponsored effort based on a crowdsourcing strategy to establish collaborations between industrial and academic partners to test and develop these therapeutic compounds was met with an overwhelming response and has led to clinical testing of a broad range of pilot projects and a newly announced round of funding opportunities. These findings are described in a Review article in the preview issue of the new journal Drug Repurposing, Rescue, and Repositioning, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Drug Repurposing, Rescue, and Repositioning website.

Christine M. Colvis, PhD and Christopher P. Austin, MD, National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Bethesda, MD, explain that the Center does not focus on a particular disease or organ system, allowing it to support a broad scope of projects that link indications with unmet medical needs to the mechanisms of action of new drug compounds that are ready to move into patient testing. In the article "The NIH-Industry New Therapeutic Uses Pilot Program: Demonstrating the Power of Crowdsourcing") the authors state that among the new funding opportunity announcements released by the Center in May were 12 therapeutic agents for pediatric indication consideration.

"This article describes not only how targeted crowdsourcing can link up the assets, the know-how, and the creativity that drug repurposing needs, but also how such a program can be organized to serve the best interests of all concerned parties," says journal Editor Hermann Mucke, PhD, H.M. Pharma Consultancy, Vienna, Austria. "Pharmaceutical companies and academia must collaborate to leverage their huge potential synergies in compound re-development, and by arranging and mentoring this pilot program NCATS has firmly established its role as a mediator in drug repurposing."


'/>"/>

Contact: Kathryn Ruehle
kruehle@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. New research about facial recognition turns common wisdom on its head
2. Commonly used pesticide turns honey bees into picky eaters
3. NTUs new loo turns poo into power
4. EyeLock Inc. Introduces EyeSwipe Nano TS Iris Scanning Turnstile Solution for Secure Access Control
5. How silver turns people blue
6. Gene find turns soldier beetle defence into biotech opportunity
7. GEOLOGY returns to Naica Cave, Mexico, and extends its reach to Mercury
8. Study turns parasite invasion theory on its head
9. Dance of water molecules turns fire-colored beetles into antifreeze artists
10. UCI research turns the corner on autism
11. AFCEAs Homeland Security Conference Returns To Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH turns to crowdsourcing to repurpose drugs
(Date:10/17/2019)... ... 15, 2019 , ... Modality Solutions, a biopharmaceutical ... on the Houston Business Journal’s Fast 100 list. Modality Solutions ranked No. 91 ... in Houston, Modality Solutions is a biopharmaceutical cold chain engineering firm with regulatory ...
(Date:10/15/2019)... ... October 14, 2019 , ... Erchonia, ... today announces its upcoming Business Meeting in Orlando & 18th Annual Golf Tournament. ... in Orlando, near Erchonia’s headquarters in Melbourne. , The first day will kick ...
(Date:10/10/2019)... ... October 10, 2019 , ... Mindray, a global developer of ... American Society of Anesthesiologists 2019 Annual Meeting to visit exhibit #841 and discover ... Florida, and will provide more than 14,000 healthcare professionals from around the world ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Catalent, a ... and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd ... Sept. 25-26, 2019. , On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney ...
(Date:9/17/2019)... ... September 17, 2019 , ... Jennifer Hermansky and ... , have been named to Law360’s 2019 Rising Stars. Hermansky and Xie, named an ... attorneys from 1,300 submissions, spanning 39 practice areas. The list highlights attorneys “whose legal ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate Global ... Focus @ Biotech Week Boston, a forum organized by MyBioGate, Inc. and CUBIO ... , After a careful process of evaluation, twelve companies out of over 200 ...
(Date:9/11/2019)... ... 10, 2019 , ... An upcoming episode of Advancements with ... genome sequencing analysis. Check your local listings for more information. , Advancements will ... Consulting and will explore its revolutionary pathogenic DNA analysis technology, which predicts in ...
Breaking Biology Technology: